MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-0941 in Japanese patients with Type 2 Diabetes.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Japanese Male or Female between 20 to 65 years of age

• Diagnosis of Type 2 Diabetes

• Patient being treated by diet and exercise alone

Exclusion Criteria:

• Patient has a history of Type 1 Diabetes

• Patient is being treated with glaucoma medications

• Patient has donated blood or participated in another clinical study in the past 12 weeks

• Patient is a regular user of any illicit drugs or has a history of drug, including alcohol, abuse